Evidence map›Paper›PMID 35416409›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis.

Brian P Lee, Nitzan Roth, Prathik Rao, Gene Y Im, Alexander S Vogel, Johann Hasbun, Yoel Roth, Akhil Shenoy, Antonios Arvelakis, Laura Ford and 14 more

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Gender disparity in access to early liver transplant among patients with alcohol associated liver disease and limited sobriety is mediated by psychosocial factors.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026
    Article
  4. Early liver transplantation in alcohol-associated liver disease-Evolution of practice, patient selection, management, and outcomes.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Proceedings of the 28th Annual Congress of the International Liver Transplantation Society.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2024
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 14 institutions in 1 country.

Brian P LeeUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.ORCID 0000-0003-2108-1287
Nitzan RothNorthwell Health, New York City, New York, USA.
Prathik RaoUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.
Gene Y ImMount Sinai Icahn School of Medicine, New York City, New York, USA.ORCID 0000-0003-0009-8418
Alexander S VogelHarvard Medical School, Boston, Massachusetts, USA.
Johann HasbunNew York University Grossman School of Medicine, New York City, New York, USA.
Yoel RothTwitter Inc, San Francisco, California, USA.
Akhil ShenoyColumbia University Vagelos College of Physicians and Surgeons, New York City, New York, USA.ORCID 0000-0001-8639-2751
Antonios ArvelakisMount Sinai Icahn School of Medicine, New York City, New York, USA.
Laura FordMount Sinai Icahn School of Medicine, New York City, New York, USA.
Inga DaweMount Sinai Icahn School of Medicine, New York City, New York, USA.
Thomas D SchianoMount Sinai Icahn School of Medicine, New York City, New York, USA.
Jordan P DavisUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.
John P RiceUniversity of Wisconsin, Madison, Wisconsin, USA.
Sheila EswaranRush Medical Center, Chicago, Illinois, USA.
Ethan WeinbergUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Hyosun HanUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.
Christine HsuGeorgetown School of Medicine, Washington, District of Columbia, USA.
Oren K FixUniversity of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Haripriya MaddurNorthwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0001-7192-9501
R Mark GhobrialHouston Methodist Hospital, Houston, Texas, USA.
George TherapondosOchsner Clinic, New Orleans, Louisiana, USA.
Bistra DilkinaUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.
Norah A TerraultUniversity of Southern California Keck School of Medicine, Los Angeles, California, USA.ORCID 0000-0003-4143-1950
University of Southern California · USIcahn School of Medicine at Mount Sinai · USColumbia University · USHarvard University · USMethodist Hospital · USNew York University · USNorthwell Health · USNorthwestern University · USOchsner Medical Center · USRush University Medical Center · USTwitter (United States) · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · USUniversity of Wisconsin–Madison · US

Funding

Molecular Mechanisms of Stellate Cell Activation in Liver FibrosisI01BX001991 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI HIDEKAZU TSUKAMOTO · 2014 to 2026
–
6 · The paper itself

Abstract

Early liver transplantation (LT) for alcohol-associated hepatitis (AH) is the fastest growing indication for LT, but prediction of harmful alcohol use post-LT remains limited. Among 10 ACCELERATE-AH centers, we examined psychosocial evaluations from consecutive LT recipients for AH from 2006 to 2017. A multidisciplinary panel used content analysis to develop a maximal list of psychosocial variables. We developed an artificial intelligence model to predict post-LT harmful alcohol use. The cohort included training (N = 91 among 8 centers) and external validation (N = 25 among 2 centers) sets, with median follow-up of 4.4 (IQR 3.0-6.0) years post-LT. In the training set, AUC was 0.930 (95%CI 0.862-0.998) with positive predictive value of 0.891 (95%CI 0.620-1.000), internally validated through fivefold cross-validation. In the external validation set, AUC was 0.692 (95%CI 0.666-0.718) with positive predictive value of 0.82 (95%CI 0.625-1.000). The model identified specific variables related to social support and substance use as highly important to predict post-LT harmful alcohol use. We retrospectively developed and validated a model that identified psychosocial profiles at LT predicting harmful alcohol use post-LT for AH. This preliminary model may inform selection and post-LT management for AH and warrants prospective evaluation in larger studies among all alcohol-associated liver disease being considered for early LT.

Indexed as

AlcoholismHepatitis, AlcoholicLiver Diseases, AlcoholicLiver TransplantationArtificial IntelligenceHumansRecurrenceRetrospective Studiesalcoholism and substance abuseclinical research/practiceliver transplantation/hepatologyrisk assessment/risk stratification

Identifiers

PMID35416409
PMCPMC9541176
OpenAlexW4223650184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.